Ukraine

Ukraine

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.3 (1.14 - 1.47) 2019 Modelled IHME
1.32 (1.17 - 1.48) 2018 Modelled IHME
1.36 (1.19 - 1.51) 2017 Modelled IHME
1.4 (1.24 - 1.56) 2016 Modelled IHME
1.44 (1.28 - 1.61) 2015 Modelled IHME
1.49 (1.32 - 1.65) 2014 Modelled IHME
1.53 (1.36 - 1.69) 2013 Modelled IHME
1.58 (1.40 - 1.74) 2012 Modelled IHME
1.62 (1.43 - 1.79) 2011 Modelled IHME
1.65 (1.46 - 1.83) 2010 Modelled IHME
1.68 (1.48 - 1.86) 2009 Modelled IHME
1.7 (1.51 - 1.88) 2008 Modelled IHME
1.73 (1.53 - 1.90) 2007 Modelled IHME
1.75 (1.53 - 1.93) 2006 Modelled IHME
1.76 (1.54 - 1.95) 2005 Modelled IHME
1.76 (1.55 - 1.95) 2004 Modelled IHME
1.76 (1.55 - 1.96) 2003 Modelled IHME
1.76 (1.56 - 1.96) 2002 Modelled IHME
1.76 (1.55 - 1.97) 2001 Modelled IHME
1.76 (1.55 - 1.97) 2000 Modelled IHME
1.76 (1.55 - 1.96) 1999 Modelled IHME
1.74 (1.53 - 1.94) 1998 Modelled IHME
1.71 (1.51 - 1.91) 1997 Modelled IHME
1.69 (1.49 - 1.89) 1996 Modelled IHME
1.68 (1.48 - 1.88) 1995 Modelled IHME
1.68 (1.47 - 1.88) 1994 Modelled IHME
1.68 (1.47 - 1.88) 1993 Modelled IHME
1.67 (1.47 - 1.89) 1992 Modelled IHME
1.67 (1.46 - 1.90) 1991 Modelled IHME
1.68 (1.45 - 1.92) 1990 Modelled IHME
1.14 (0.76 - 1.68) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.29 (0.23 - 0.35) 2019 Modelled IHME
0.3 (0.25 - 0.36) 2018 Modelled IHME
0.33 (0.27 - 0.41) 2017 Modelled IHME
0.68 (0.56 - 0.81) 2016 Modelled IHME
1 (0.81 - 1.22) 2015 Modelled IHME
0.98 (0.79 - 1.17) 2014 Modelled IHME
0.9 (0.74 - 1.08) 2013 Modelled IHME
0.81 (0.65 - 0.96) 2012 Modelled IHME
0.71 (0.57 - 0.84) 2011 Modelled IHME
0.62 (0.50 - 0.74) 2010 Modelled IHME
0.54 (0.43 - 0.64) 2009 Modelled IHME
0.44 (0.36 - 0.53) 2008 Modelled IHME
0.36 (0.29 - 0.43) 2007 Modelled IHME
0.3 (0.24 - 0.36) 2006 Modelled IHME
0.27 (0.22 - 0.33) 2005 Modelled IHME
0.4 (0.33 - 0.48) 2004 Modelled IHME
0.71 (0.58 - 0.84) 2003 Modelled IHME
1.07 (0.88 - 1.28) 2002 Modelled IHME
1.38 (1.13 - 1.66) 2001 Modelled IHME
1.51 (1.23 - 1.83) 2000 Modelled IHME
1.51 (1.24 - 1.82) 1999 Modelled IHME
1.51 (1.25 - 1.80) 1998 Modelled IHME
1.51 (1.25 - 1.78) 1997 Modelled IHME
1.51 (1.24 - 1.77) 1996 Modelled IHME
1.51 (1.24 - 1.77) 1995 Modelled IHME
1.51 (1.25 - 1.76) 1994 Modelled IHME
1.51 (1.25 - 1.76) 1993 Modelled IHME
1.51 (1.25 - 1.78) 1992 Modelled IHME
1.51 (1.23 - 1.79) 1991 Modelled IHME
1.52 (1.21 - 1.82) 1990 Modelled IHME
0.46 (0.30 - 0.72) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
883,205 (764,521 - 1,011,040) 1990 Modelled IHME
880,760 (766,309 - 1,000,440) 1991 Modelled IHME
877,877 (769,039 - 988,845) 1992 Modelled IHME
874,440 (768,137 - 982,134) 1993 Modelled IHME
870,344 (764,910 - 974,007) 1994 Modelled IHME
865,474 (761,774 - 968,052) 1995 Modelled IHME
864,149 (762,098 - 966,379) 1996 Modelled IHME
868,327 (765,555 - 971,400) 1997 Modelled IHME
874,489 (772,522 - 979,094) 1998 Modelled IHME
878,529 (774,282 - 980,667) 1999 Modelled IHME
876,282 (769,779 - 979,860) 2000 Modelled IHME
869,574 (765,373 - 970,988) 2001 Modelled IHME
862,304 (761,357 - 961,071) 2002 Modelled IHME
854,630 (752,797 - 949,028) 2003 Modelled IHME
846,682 (745,261 - 938,070) 2004 Modelled IHME
838,534 (737,427 - 929,402) 2005 Modelled IHME
828,156 (727,306 - 915,959) 2006 Modelled IHME
813,965 (718,177 - 896,755) 2007 Modelled IHME
797,145 (704,478 - 878,627) 2008 Modelled IHME
779,652 (689,625 - 862,611) 2009 Modelled IHME
762,814 (674,618 - 846,437) 2010 Modelled IHME
744,790 (660,052 - 822,696) 2011 Modelled IHME
723,892 (644,806 - 796,837) 2012 Modelled IHME
701,123 (623,739 - 772,887) 2013 Modelled IHME
677,796 (602,746 - 750,283) 2014 Modelled IHME
654,316 (578,495 - 728,889) 2015 Modelled IHME
629,140 (558,355 - 700,441) 2016 Modelled IHME
606,151 (532,067 - 676,173) 2017 Modelled IHME
587,975 (519,739 - 656,403) 2018 Modelled IHME
572,970 (503,641 - 646,562) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.63 (6.74 - 10.80) 2019 Modelled IHME
8.2 (6.54 - 10.10) 2018 Modelled IHME
7.88 (6.51 - 9.42) 2017 Modelled IHME
7.76 (6.61 - 9.08) 2016 Modelled IHME
7.95 (6.78 - 9.33) 2015 Modelled IHME
6.61 (5.65 - 7.69) 2014 Modelled IHME
8.02 (6.85 - 9.35) 2013 Modelled IHME
9.13 (7.82 - 10.60) 2012 Modelled IHME
9.94 (8.58 - 11.50) 2011 Modelled IHME
10.9 (9.31 - 12.60) 2010 Modelled IHME
11.8 (10.10 - 13.70) 2009 Modelled IHME
13.9 (11.90 - 16.10) 2008 Modelled IHME
13.4 (11.50 - 15.70) 2007 Modelled IHME
12.2 (10.40 - 14.20) 2006 Modelled IHME
12.1 (10.30 - 14.10) 2005 Modelled IHME
10.9 (9.30 - 12.60) 2004 Modelled IHME
9.55 (8.21 - 11) 2003 Modelled IHME
8.73 (7.49 - 10.10) 2002 Modelled IHME
7.83 (6.70 - 9.02) 2001 Modelled IHME
7.33 (6.28 - 8.42) 2000 Modelled IHME
6.54 (5.61 - 7.52) 1999 Modelled IHME
5.97 (5.14 - 6.89) 1998 Modelled IHME
6.19 (5.34 - 7.14) 1997 Modelled IHME
6.27 (5.42 - 7.27) 1996 Modelled IHME
6.14 (5.29 - 7.19) 1995 Modelled IHME
5.35 (4.64 - 6.23) 1994 Modelled IHME
4.88 (4.24 - 5.69) 1993 Modelled IHME
4.51 (3.91 - 5.26) 1992 Modelled IHME
4.12 (3.56 - 4.82) 1991 Modelled IHME
3.73 (3.23 - 4.36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,799 (2,968 - 4,764) 2019 Modelled IHME
3,641 (2,901 - 4,462) 2018 Modelled IHME
3,521 (2,908 - 4,210) 2017 Modelled IHME
3,493 (2,974 - 4,085) 2016 Modelled IHME
3,600 (3,070 - 4,226) 2015 Modelled IHME
3,008 (2,572 - 3,503) 2014 Modelled IHME
3,665 (3,130 - 4,276) 2013 Modelled IHME
4,190 (3,590 - 4,878) 2012 Modelled IHME
4,582 (3,954 - 5,316) 2011 Modelled IHME
5,033 (4,308 - 5,830) 2010 Modelled IHME
5,496 (4,716 - 6,371) 2009 Modelled IHME
6,482 (5,545 - 7,546) 2008 Modelled IHME
6,329 (5,412 - 7,378) 2007 Modelled IHME
5,779 (4,951 - 6,727) 2006 Modelled IHME
5,767 (4,912 - 6,743) 2005 Modelled IHME
5,247 (4,480 - 6,086) 2004 Modelled IHME
4,635 (3,984 - 5,359) 2003 Modelled IHME
4,271 (3,663 - 4,928) 2002 Modelled IHME
3,861 (3,305 - 4,445) 2001 Modelled IHME
3,642 (3,118 - 4,183) 2000 Modelled IHME
3,271 (2,805 - 3,761) 1999 Modelled IHME
3,006 (2,589 - 3,470) 1998 Modelled IHME
3,140 (2,709 - 3,624) 1997 Modelled IHME
3,204 (2,769 - 3,718) 1996 Modelled IHME
3,166 (2,724 - 3,702) 1995 Modelled IHME
2,774 (2,409 - 3,231) 1994 Modelled IHME
2,548 (2,213 - 2,968) 1993 Modelled IHME
2,365 (2,048 - 2,758) 1992 Modelled IHME
2,164 (1,873 - 2,532) 1991 Modelled IHME
1,963 (1,703 - 2,294) 1990 Modelled IHME
4,746 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (20 - 27) 2019 Modelled IHME
23 (19 - 27) 2018 Modelled IHME
23 (19 - 27) 2017 Modelled IHME
23 (20 - 27) 2016 Modelled IHME
23 (20 - 27) 2015 Modelled IHME
22 (19 - 26) 2014 Modelled IHME
23 (20 - 27) 2013 Modelled IHME
24 (21 - 28) 2012 Modelled IHME
24 (21 - 28) 2011 Modelled IHME
25 (21 - 29) 2010 Modelled IHME
25 (22 - 29) 2009 Modelled IHME
25 (22 - 30) 2008 Modelled IHME
25 (22 - 29) 2007 Modelled IHME
25 (21 - 29) 2006 Modelled IHME
25 (21 - 29) 2005 Modelled IHME
24 (20 - 28) 2004 Modelled IHME
23 (20 - 27) 2003 Modelled IHME
23 (20 - 27) 2002 Modelled IHME
23 (20 - 27) 2001 Modelled IHME
23 (20 - 27) 2000 Modelled IHME
23 (20 - 27) 1999 Modelled IHME
23 (20 - 27) 1998 Modelled IHME
23 (20 - 27) 1997 Modelled IHME
23 (20 - 28) 1996 Modelled IHME
24 (20 - 28) 1995 Modelled IHME
23 (20 - 27) 1994 Modelled IHME
23 (20 - 27) 1993 Modelled IHME
23 (20 - 27) 1992 Modelled IHME
23 (20 - 27) 1991 Modelled IHME
23 (20 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
49 2018 Survey/reported WHO/UNICEF
49 2017 Survey/reported WHO/UNICEF
37 2016 Survey/reported WHO/UNICEF
57 2015 Survey/reported WHO/UNICEF
57 2014 Survey/reported WHO/UNICEF
51 2013 Survey/reported WHO/UNICEF
51 2012 Survey/reported WHO/UNICEF
53 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
73 2009 Survey/reported WHO/UNICEF
82 2008 Survey/reported WHO/UNICEF
89 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
85 2003 Survey/reported WHO/UNICEF
70 2002 Survey/reported WHO/UNICEF
34 2001 Survey/reported WHO/UNICEF
60 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
52 2018 Survey/reported WHO/UNICEF
52 2017 Survey/reported WHO/UNICEF
26 2016 Survey/reported WHO/UNICEF
22 2015 Survey/reported WHO/UNICEF
22 2014 Survey/reported WHO/UNICEF
46 2013 Survey/reported WHO/UNICEF
46 2012 Survey/reported WHO/UNICEF
21 2011 Survey/reported WHO/UNICEF
48 2010 Survey/reported WHO/UNICEF
66 2009 Survey/reported WHO/UNICEF
84 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
96 2006 Survey/reported WHO/UNICEF
97 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
77 2003 Survey/reported WHO/UNICEF
48 2002 Survey/reported WHO/UNICEF
7 2001 Survey/reported WHO/UNICEF
4 2000 Survey/reported WHO/UNICEF
76 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
61 (33 - 113) 2015 Survey/reported Alliance for Publi Health, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
5 (4.60 - 5.50) 2015 Survey/reported Barska G and Sazanov JA, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.7 (2.18 - 3.34) 2019 Modelled IHME
2.72 (2.19 - 3.36) 2018 Modelled IHME
2.72 (2.20 - 3.38) 2017 Modelled IHME
2.68 (2.17 - 3.29) 2016 Modelled IHME
2.64 (2.12 - 3.24) 2015 Modelled IHME
2.63 (2.12 - 3.22) 2014 Modelled IHME
2.62 (2.12 - 3.22) 2013 Modelled IHME
2.61 (2.11 - 3.22) 2012 Modelled IHME
2.61 (2.11 - 3.22) 2011 Modelled IHME
2.6 (2.10 - 3.22) 2010 Modelled IHME
2.58 (2.08 - 3.21) 2009 Modelled IHME
2.56 (2.06 - 3.18) 2008 Modelled IHME
2.53 (2.03 - 3.15) 2007 Modelled IHME
2.5 (2.01 - 3.11) 2006 Modelled IHME
2.47 (1.98 - 3.08) 2005 Modelled IHME
2.45 (1.97 - 3.04) 2004 Modelled IHME
2.42 (1.95 - 2.99) 2003 Modelled IHME
2.39 (1.92 - 2.96) 2002 Modelled IHME
2.36 (1.90 - 2.91) 2001 Modelled IHME
2.32 (1.88 - 2.87) 2000 Modelled IHME
2.28 (1.83 - 2.80) 1999 Modelled IHME
2.22 (1.80 - 2.73) 1998 Modelled IHME
2.16 (1.75 - 2.67) 1997 Modelled IHME
2.11 (1.70 - 2.61) 1996 Modelled IHME
2.07 (1.66 - 2.57) 1995 Modelled IHME
2.04 (1.64 - 2.54) 1994 Modelled IHME
2.01 (1.62 - 2.50) 1993 Modelled IHME
1.99 (1.60 - 2.47) 1992 Modelled IHME
1.98 (1.58 - 2.46) 1991 Modelled IHME
1.97 (1.57 - 2.44) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.6 (0.90 - 4.50) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
53.9 (49.20 - 58.70) 2015 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,036,400 (828,702 - 1,287,340) 1990 Modelled IHME
1,039,180 (832,268 - 1,291,630) 1991 Modelled IHME
1,044,310 (838,864 - 1,296,490) 1992 Modelled IHME
1,050,900 (843,763 - 1,306,520) 1993 Modelled IHME
1,058,090 (852,188 - 1,316,050) 1994 Modelled IHME
1,065,000 (857,486 - 1,326,160) 1995 Modelled IHME
1,076,690 (869,778 - 1,335,540) 1996 Modelled IHME
1,095,890 (888,394 - 1,352,660) 1997 Modelled IHME
1,118,490 (907,556 - 1,375,740) 1998 Modelled IHME
1,139,650 (917,912 - 1,402,540) 1999 Modelled IHME
1,154,380 (932,459 - 1,423,190) 2000 Modelled IHME
1,163,310 (938,898 - 1,436,140) 2001 Modelled IHME
1,169,850 (941,491 - 1,447,390) 2002 Modelled IHME
1,174,720 (945,400 - 1,453,800) 2003 Modelled IHME
1,178,620 (947,089 - 1,464,560) 2004 Modelled IHME
1,182,120 (947,193 - 1,471,910) 2005 Modelled IHME
1,186,870 (952,260 - 1,476,900) 2006 Modelled IHME
1,192,570 (957,699 - 1,480,800) 2007 Modelled IHME
1,197,590 (962,699 - 1,486,080) 2008 Modelled IHME
1,201,550 (968,518 - 1,491,010) 2009 Modelled IHME
1,203,290 (971,012 - 1,487,850) 2010 Modelled IHME
1,202,380 (971,013 - 1,483,680) 2011 Modelled IHME
1,200,240 (968,174 - 1,477,460) 2012 Modelled IHME
1,197,620 (969,071 - 1,470,550) 2013 Modelled IHME
1,195,800 (964,100 - 1,466,620) 2014 Modelled IHME
1,194,420 (961,265 - 1,469,430) 2015 Modelled IHME
1,206,920 (974,925 - 1,480,720) 2016 Modelled IHME
1,216,030 (982,639 - 1,510,660) 2017 Modelled IHME
1,206,280 (970,888 - 1,491,220) 2018 Modelled IHME
1,189,650 (958,376 - 1,471,030) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.76 (7.76 - 12.10) 2019 Modelled IHME
9.91 (8.06 - 12.10) 2018 Modelled IHME
10 (8.30 - 11.80) 2017 Modelled IHME
10.3 (8.84 - 11.80) 2016 Modelled IHME
10.7 (9.17 - 12.40) 2015 Modelled IHME
8.21 (7.13 - 9.52) 2014 Modelled IHME
8.49 (7.36 - 9.83) 2013 Modelled IHME
8.16 (7.08 - 9.49) 2012 Modelled IHME
7.86 (6.78 - 9.14) 2011 Modelled IHME
8.16 (7.08 - 9.47) 2010 Modelled IHME
8.83 (7.61 - 10.20) 2009 Modelled IHME
10.3 (8.86 - 11.90) 2008 Modelled IHME
10 (8.64 - 11.70) 2007 Modelled IHME
9.16 (7.89 - 10.60) 2006 Modelled IHME
9.08 (7.82 - 10.60) 2005 Modelled IHME
8.21 (7.08 - 9.55) 2004 Modelled IHME
7.2 (6.22 - 8.39) 2003 Modelled IHME
6.57 (5.68 - 7.63) 2002 Modelled IHME
5.89 (5.10 - 6.83) 2001 Modelled IHME
5.51 (4.76 - 6.39) 2000 Modelled IHME
4.94 (4.28 - 5.70) 1999 Modelled IHME
4.53 (3.90 - 5.22) 1998 Modelled IHME
4.69 (4.07 - 5.42) 1997 Modelled IHME
4.75 (4.11 - 5.50) 1996 Modelled IHME
4.66 (4.02 - 5.42) 1995 Modelled IHME
4.08 (3.52 - 4.72) 1994 Modelled IHME
3.73 (3.23 - 4.32) 1993 Modelled IHME
3.45 (2.99 - 4) 1992 Modelled IHME
3.15 (2.74 - 3.67) 1991 Modelled IHME
2.86 (2.49 - 3.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,298 (3,416 - 5,344) 2019 Modelled IHME
4,397 (3,575 - 5,351) 2018 Modelled IHME
4,468 (3,710 - 5,275) 2017 Modelled IHME
4,616 (3,977 - 5,331) 2016 Modelled IHME
4,843 (4,155 - 5,624) 2015 Modelled IHME
3,736 (3,246 - 4,333) 2014 Modelled IHME
3,879 (3,367 - 4,495) 2013 Modelled IHME
3,744 (3,249 - 4,355) 2012 Modelled IHME
3,620 (3,125 - 4,212) 2011 Modelled IHME
3,777 (3,275 - 4,383) 2010 Modelled IHME
4,104 (3,536 - 4,751) 2009 Modelled IHME
4,818 (4,141 - 5,586) 2008 Modelled IHME
4,726 (4,069 - 5,494) 2007 Modelled IHME
4,342 (3,741 - 5,039) 2006 Modelled IHME
4,338 (3,736 - 5,052) 2005 Modelled IHME
3,955 (3,411 - 4,601) 2004 Modelled IHME
3,496 (3,019 - 4,071) 2003 Modelled IHME
3,215 (2,777 - 3,732) 2002 Modelled IHME
2,905 (2,515 - 3,367) 2001 Modelled IHME
2,739 (2,362 - 3,173) 2000 Modelled IHME
2,470 (2,139 - 2,853) 1999 Modelled IHME
2,281 (1,967 - 2,631) 1998 Modelled IHME
2,381 (2,063 - 2,750) 1997 Modelled IHME
2,429 (2,101 - 2,812) 1996 Modelled IHME
2,403 (2,069 - 2,792) 1995 Modelled IHME
2,115 (1,825 - 2,452) 1994 Modelled IHME
1,949 (1,688 - 2,253) 1993 Modelled IHME
1,811 (1,567 - 2,099) 1992 Modelled IHME
1,658 (1,441 - 1,929) 1991 Modelled IHME
1,505 (1,310 - 1,754) 1990 Modelled IHME
3,186 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
29 (25 - 33) 2019 Modelled IHME
29 (25 - 33) 2018 Modelled IHME
29 (25 - 33) 2017 Modelled IHME
29 (26 - 33) 2016 Modelled IHME
29 (25 - 32) 2015 Modelled IHME
30 (26 - 33) 2014 Modelled IHME
29 (26 - 33) 2013 Modelled IHME
29 (25 - 32) 2012 Modelled IHME
28 (25 - 32) 2011 Modelled IHME
28 (24 - 32) 2010 Modelled IHME
28 (24 - 31) 2009 Modelled IHME
27 (24 - 31) 2008 Modelled IHME
28 (24 - 31) 2007 Modelled IHME
28 (25 - 32) 2006 Modelled IHME
28 (25 - 32) 2005 Modelled IHME
29 (26 - 33) 2004 Modelled IHME
30 (26 - 34) 2003 Modelled IHME
30 (27 - 34) 2002 Modelled IHME
31 (27 - 35) 2001 Modelled IHME
31 (27 - 35) 2000 Modelled IHME
31 (28 - 35) 1999 Modelled IHME
32 (28 - 36) 1998 Modelled IHME
31 (28 - 35) 1997 Modelled IHME
31 (28 - 35) 1996 Modelled IHME
31 (28 - 35) 1995 Modelled IHME
32 (28 - 36) 1994 Modelled IHME
32 (28 - 36) 1993 Modelled IHME
32 (28 - 36) 1992 Modelled IHME
32 (28 - 36) 1991 Modelled IHME
32 (28 - 36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
61 (33 - 113) 2015 Survey/reported Alliance for Publi Health, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
5 (4.60 - 5.50) 2015 Survey/reported Barska G and Sazanov JA, 2016

Number of persons treated for HCV

National
Download
Value Year Type Source
2,000 2015 Survey/reported WHO, 2018
2,500 2016 Survey/reported WHO, 2018
Showing out of
Show more
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3,799
2019
(2,968 - 4,764)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4,298
2019
(3,416 - 5,344)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
60 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
61
2015
(33 - 113)
Alliance for Publi Health, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources